VC005 not checked
Jiangsu vcare pharmaceutical technology co., LTD
FollowEvery change as it happens, and a Monday email
Trials
9 active
21 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “A single dose of metformin was administered in the period 1. and a single dose of metformin and VC005 coadministration in the period 2”In the company’s words, NCT07796191 on ClinicalTrials.gov
- Tested for
- Atopic Dermatitis (2 trials), Non-segmental Vitiligo (2 trials), Alopecia Areata (2 trials), Active Ankylosing Spondylitis, Moderate to Severe Atopic Dermatitis
- Main trialPhase 3
- “This clinical trial is a multicenter, randomized, double-blind, controlled phase III clinical study.”In the company’s words, NCT07172360 on ClinicalTrials.gov
Other drugs for Atopic Dermatitis
- ICP-332Beijing InnoCare Pharma Tech Co., Ltd. · Phase 3
- UpadacitinibAbbVie · Phase 3
- OPA-15406Otsuka · Phase 3
- MG-K10Shanghai Mabgeek Biotech.Co.Ltd · Phase 3
- GX-03Turn Therapeutics · Phase 2/3
- StapokibartKeymed Biosciences Co.Ltd · Phase 3
Coming up9
- 30 NovPhase 1 trial completes · ClinicalTrials.gov
- 22 Feb 2027Phase 2 trial completes · ClinicalTrials.gov
- 30 May 2027Phase 1/2 trial completes · ClinicalTrials.gov
- 30 Aug 2027Phase 3 trial completes · ClinicalTrials.gov
- 30 Aug 2027Phase 3 trial completes · ClinicalTrials.gov
- 30 Aug 2027Phase 2 trial completes · ClinicalTrials.gov
- 30 Dec 2027Phase 1 trial completes · ClinicalTrials.gov
- 30 May 2028Phase 3 trial completes · ClinicalTrials.gov
- 30 Dec 2028Phase 2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials21
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Recruiting | 30 Aug 2027 | Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis. | |
| Phase 3Recruiting | 30 Aug 2027 | Phase III Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis | |
| Phase 3Recruiting | 30 May 2028 | Phase III Clinical Study of VC005 in Adult and Adolescents With Mild to Moderate Atopic Dermatitis | |
| Phase 2Recruiting | 22 Feb 2027 | A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in Adult Subjects With Mild to Moderate Atopic Dermatitis | |
| Phase 2Recruiting | 30 Aug 2027 | Efficacy and Safety Phase II Study of VC005 Tablets in Subjects With Non-segmental Vitiligo | |
| Phase 2Recruiting | 30 Dec 2028 | Phase II Clinical Study of VC005 Tablets in Subjects With Severe Alopecia Areata | |
| Phase 1/2Not yet recruiting | 30 May 2027 | A Study of VC005 Tablets in Adolescent Subjects With Non-Segmental Vitiligo | |
| Phase 1Not yet recruiting | 30 Nov 2026 | Drug-drug Interactions Studies of VC005 Tablets in Healthy Adult Subjects | |
| Phase 1Recruiting | 30 Dec 2027 | A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia Areata | |
| Phase 2Completed | 11 May 2024 | Efficacy and Safety Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis. | |
| Phase 2Completed | 9 Jul 2024 | Efficacy and Safety Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis | |
| Phase 2Completed | 31 Oct 2025 | Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult Subjects With Mild to Moderate Atopic Dermatitis | |
| Phase 1Completed | 26 Aug 2022 | Pharmacokinetics and Pharmacodynamics Clinical Study of VC005 Tablets in Healthy Subjects | |
| Phase 1Completed | 2 Nov 2022 | Multiple-dose Escalation Clinical Study of VC005 Tablets in Healthy Subjects | |
| Phase 1Completed | 18 Oct 2023 | A Phase I Clinical Study of VC005 Tablets in Subjects With Rheumatoid Arthritis. | |
| Phase 1Completed | 23 May 2024 | Safety, Tolerance and Pharmacokinetics Clinical Study of VC005 in Healthy Subjects and Patients with Mild to Moderate Atopic Dermatitis | |
| Phase 1Completed | 3 Jun 2025 | The Mass Balance and Biotransformation Study of [14C] VC005 in Chinese Healthy Adult Male Volunteers | |
| Phase 1Completed | 6 Feb 2026 | Clinical Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VC005 in Adolescent Subjects With Mild to Moderate Atopic Dermatitis | |
| Phase 1Completed | 30 Apr 2026 | A Food Effect Study of VC005 Tablets in Healthy Adult Subjects. | |
| Phase 1Completed | 2 Aug 2026 | Pharmacokinetics of VC005 Tablets in Subjects With Hepatic Impairment and Normal Hepatic Function | |
| Phase 1Completed | 2 Aug 2026 | Pharmacokinetics of VC005 Tablets in Subjects With Renal Impairment and Normal Renal Function |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026